Norges Bank’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,539,334
| Closed | -$164M | – | 1989 |
|
|
2023
Q4 | $164M | Buy |
5,539,334
+3,484,245
| +170% | +$69.4M | 0.03% | 462 |
|
|
2023
Q3 | $32.6M | Buy |
2,055,089
+1,890,089
| +1,146% | +$31.4M | 0.01% | 1026 |
|
|
2023
Q2 | $3.11M | Buy |
+165,000
| New | +$1.95M | ﹤0.01% | 1819 |
|
|
2022
Q3 | – | Sell |
-114,900
| Closed | -$517K | – | 2144 |
|
|
2022
Q2 | $517K | Sell |
114,900
-1,820,000
| -94% | -$7.91M | ﹤0.01% | 2008 |
|
|
2022
Q1 | $9.21M | Hold |
1,934,900
| – | – | ﹤0.01% | 1732 |
|
|
2021
Q4 | $14.4M | Buy |
+1,934,900
| New | +$12M | ﹤0.01% | 1618 |
|
|
2020
Q3 | – | Sell |
-661,600
| Closed | -$3.04M | – | 2170 |
|
|
2020
Q2 | $3.04M | Buy |
+661,600
| New | +$2.81M | ﹤0.01% | 1921 |
|
|
2019
Q4 | – | Sell |
-231,752
| Closed | -$561K | – | 2100 |
|
|
2019
Q3 | $561K | Hold |
231,752
| – | – | ﹤0.01% | 2058 |
|
|
2019
Q2 | $503K | Sell |
231,752
-196,631
| -46% | -$465K | ﹤0.01% | 2056 |
|
|
2019
Q1 | $1.16M | Hold |
428,383
| – | – | ﹤0.01% | 2044 |
|
|
2018
Q4 | $2.06M | Sell |
428,383
-105,596
| -20% | -$641K | ﹤0.01% | 2003 |
|
|
2018
Q3 | $5.06M | Hold |
533,979
| – | – | ﹤0.01% | 1967 |
|
|
2018
Q2 | $5.2M | Buy |
533,979
+200,000
| +60% | +$2.11M | ﹤0.01% | 1941 |
|
|
2018
Q1 | $3.51M | Hold |
333,979
| – | – | ﹤0.01% | 1940 |
|
|
2017
Q4 | $2.14M | Hold |
333,979
| – | – | ﹤0.01% | 1970 |
|
|
2017
Q3 | $2.56M | Hold |
333,979
| – | – | ﹤0.01% | 1950 |
|
|
2017
Q2 | $2.38M | Sell |
333,979
-1,196,793
| -78% | -$5.48M | ﹤0.01% | 1968 |
|
|
2017
Q1 | $5.92M | Hold |
1,530,772
| – | – | ﹤0.01% | 1860 |
|
|
2016
Q4 | $3.12M | Hold |
1,530,772
| – | – | ﹤0.01% | 1934 |
|
|
2016
Q3 | $3.92M | Hold |
1,530,772
| – | – | ﹤0.01% | 1912 |
|
|
2016
Q2 | $4.71M | Hold |
1,530,772
| – | – | ﹤0.01% | 1883 |
|
|
2016
Q1 | $13M | Hold |
1,530,772
| – | – | 0.01% | 1421 |
|
|
2015
Q4 | $20.8M | Hold |
1,530,772
| – | – | 0.01% | 1145 |
|
|
2015
Q3 | $14.7M | Sell |
1,530,772
-109,617
| -7% | -$1.6M | 0.01% | 1318 |
|
|
2015
Q2 | $23.6M | Hold |
1,640,389
| – | – | 0.01% | 1101 |
|
|
2015
Q1 | $14.7M | Buy |
1,640,389
+159,236
| +11% | +$1.15M | 0.01% | 1413 |
|
|
2014
Q4 | $9.04M | Buy |
1,481,153
+641,591
| +76% | +$5.87M | ﹤0.01% | 1683 |
|
|
2014
Q3 | $8.89M | Sell |
839,562
-1,339,562
| -61% | -$15.2M | ﹤0.01% | 1660 |
|
|
2014
Q2 | $25.8M | Buy |
2,179,124
+570,562
| +35% | +$7.16M | 0.01% | 1475 |
|
|
2014
Q1 | $24M | Sell |
1,608,562
-764,378
| -32% | -$12.1M | 0.01% | 1018 |
|
|
2013
Q4 | $34.8M | Sell |
2,372,940
-30,915
| -1% | -$475K | 0.02% | 765 |
|
|
2013
Q3 | $40.9M | Buy |
2,403,855
+1,781,777
| +286% | +$31.3M | 0.02% | 667 |
|
|
2013
Q2 | $10.3M | Buy |
+622,078
| New | +$10.1M | 0.01% | 1452 |
|
Other funds holding IMGN
Norges Bank's IMGN Position: Q1 2024 in Review
Norges Bank sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 5,539,334 shares — an estimated $164M sold.
Norges Bank first reported a position in IMGN in Q2 2013 and held it in 33 quarters. The position peaked at $164M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Norges Bank reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Norges Bank sold 5,539,334 Immunogen Inc shares in Q1 2024, an estimated $164M.
- Norges Bank first reported a position in Immunogen Inc in Q2 2013 and held it in 33 quarters.
- Norges Bank's Immunogen Inc position peaked at $164M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.